1887

Journal of General Virology header logo

Volume 77, Issue 6

Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection Free

Abstract

Expression from the human parvovirus B19p6 promoter fused to the firefly luciferase (‘Luc’) reporter gene was evaluated in a non-erythroid human nasopharyngeal carcinoma cell line, KB, and a human megakaryocytic leukaemia cell line, MB-02, known to become permissive for B19 replication following erythroid-differentiation. The B19p6-Luc construct was introduced into KB and MB-02 cells, both in undifferentiated and differentiated states, either via DNA-mediated transfection, or via infection with recombinant adeno-associated virus 2 (AAV), a non-pathogenic human parvovirus known to possess a broad host-range. Although Luc activity was readily detected in KB cells following transfection of the B19p6-Luc plasmid DNA, no expression from the B19p6 promoter was observed following infection with recombinant virus. In addition, transfection of the reporter plasmid resulted in high-level expression of Luc in differentiated but not in undifferentiated MB-02 cells. However, no Luc activity was detected, even in differentiated MB-02 cells, following infection with recombinant virus. Further studies with an additional recombinant as well as wild-type (wt) AAV revealed that MB-02 cells were non-permissive for AAV infection. A second human megakaryocytic leukaemia cell line, M07e, was likewise resistant to infection by recombinant as well as wt AAV. Taken together, these studies identify the first human cell type that cannot be infected by AAV. They indicate that expression from the B19p6 promoter, in the context of an AAV genome, is restricted to primary human haematopoietic cells, perhaps because parvoviral DNA replication and transcription are intrinsically coupled.

  • Received:
  • Accepted:
  • Published Online:
© Journal of General Virology 1996
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-77-6-1111
1996-06-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/77/6/JV0770061111.html?itemId=/content/journal/jgv/10.1099/0022-1317-77-6-1111&mimeType=html&fmt=ahah

References

  1. Anderson M. J., Jones S. E., Fisher-Hoch S. P., Lewis E., Hall S. M., Bartlett C. L. R., Cohen B. J., Mortimer P. P., Pereira M. S. 1983; Human parvovirus, the cause of erythema infectiosum (fifth disease)?. Lancet i:1378
     [Google Scholar]
  2. Anderson M. J., Higgins P. G., Davis L. R., Williams J. S., Jones S. E., Kidd I. M., Pattison J. R., Tyrell D. A. J. 1985; Experimental parvoviral infection in humans. Journal of Infectious Diseases 62:257–265
     [Google Scholar]
  3. Blundell M. C., Beard C., Astell C. R. 1987; In vitro identification of a B19 parvovirus promoter. Virology 157:534–538
     [Google Scholar]
  4. Brown T. A., Anand A., Ritchie L. D., Clewley J. P., Reid T. M. S. 1984; Intrauterine parvovirus infection associated with hydrops fetalis. Lancet ii:1033–1034
     [Google Scholar]
  5. Brown K. E., Anderson S. M., Young N. S. 1993; Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114–117
     [Google Scholar]
  6. Brown K. E., Young N. S., Liu J. M. 1994; Molecular, cellular and clinical aspects of parvovirus B19 infection. Critical Reviews in Oncology and Hematology 16:1–31
     [Google Scholar]
  7. Cossart Y. E., Field A. M., Cant B., Widdows D. 1975; Parvovirus like particles in human sera. Lancet i:72–73
     [Google Scholar]
  8. Curiel D. T., Wagner E., Cotten M., Birnstiel M.-L., Agarwal S., Li C. M., Hu P.-C. 1992; High-efficiency gene transfer mediated by adenovirus coupled to DNA-polylysine complexes. Human Gene Therapy 3:147–154
     [Google Scholar]
  9. DeWet J. R., Wood K. V., DeLuca M., Helsinki D. R., Subramani S. 1987; Firefly luciferase gene: structure and expression in mammalian cells. Molecular and Cellular Biology 7:725–737
     [Google Scholar]
  10. Doerig C., Beard P., Hirt B. 1987; A transcriptional promoter of the human parvovirus B19 active in vitro and in vivo. Virology 157:539–542
     [Google Scholar]
  11. Doerig C., Hirt B., Antonietti J. P., Beard P. 1990; Non-structural protein of parvoviruses B19 and minute virus of mice controls transcription. Journal of Virology 64:387–396
     [Google Scholar]
  12. Hendrie P. C., Miyazawa K., Yang Y. C., Langefeld C.-D., Broxmeyer H. E. 1991; Mast cell growth factor (c-kit ligand) enhances stimulation of proliferation of human factor dependent cell line M07e. Experimental Hematology 19:1031–1037
     [Google Scholar]
  13. Hirt B. 1967; Selective extraction of polyoma DNA from infected mouse cultures. Journal of Molecular Biology 26:365–369
     [Google Scholar]
  14. Kurtzman G. J., Ozawa K., Cohen B. J., Hansen G. R., Oseas R., Young N. S. 1986; Chronic bone marrow failure due to persistent B19 parvovirus infection. New England Journal of Medicine 317:287–293
     [Google Scholar]
  15. Liu J. M., Fujii M., Green S. W., Komatsu N., Young N. S., Shimada T. 1991; Indiscriminate activity from the B19 parvovirus p6 promoter in non-permissive cells. Virology 182:361–364
     [Google Scholar]
  16. Liu J. M., Green S. W., Shimada T., Young N. S. 1992; A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus. Journal of Virology 66:4686–4692
     [Google Scholar]
  17. Luo F., Zhou S. Z., Cooper S., Munshi N. C., Boswell H. S., Broxmeyer H. E., Srivastava A. 1995; Adeno-associated virus 2-mediated gene transfer and functional expression of the human granulocyte-macrophage colony-stimulating factor. Experimental Hematology 13:1261–1267
     [Google Scholar]
  18. Morgan D. A., Gumuchio D. L., Brodsky I. 1991; Granulocytemacrophage colony-stimulating factor dependent growth and erythropoietin-induced differentiation of a human cell line MB-02. Blood 78:2860–2871
     [Google Scholar]
  19. Munshi N. C., Zhou S. Z., Woody M. J., Morgan D. A., Srivastava A. 1993; Successful replication of parvovirus B19 in the human megakaryocytic leukemia cell line MB-02. Journal of Virology 67:562–566
     [Google Scholar]
  20. Muzyczka N. 1992; Use of adeno-associated virus as a general transduction vector for mammalian cells. Current Topics in Microbiology and Immunology 158:97–129
     [Google Scholar]
  21. Nahreini P., Srivastava A. 1989; Rescue and replication of the adeno-associated virus 2 genome in mortal and immortal human cells. Intervirology 30:74–85
     [Google Scholar]
  22. Nahreini P., Srivastava A. 1992; Rescue of the adeno-associated virus 2 genome correlates with alterations in DNA-modifying enzymes in human cells. Intervirology 33:109–115
     [Google Scholar]
  23. Nahreini P., Woody M. J., Zhou S. Z., Srivastava A. 1993; Versatile adeno-associated virus 2-based vectors for constructing recombinant virions. Gene 124:257–262
     [Google Scholar]
  24. Ozawa K., Kurtzman G. J., Young N. S. 1986; Replication of the B19 parvovirus in human bone marrow cultures. Science 233:883–886
     [Google Scholar]
  25. Ozawa K., Ayub J., Yu-Shu H., Kurtzman G. J., Shimada T., Young N. S. 1987a; Novel transcription map for the B19 (human) pathogenic parvovirus. Journal of Virology 61:2395–2406
     [Google Scholar]
  26. Ozawa K., Kurtzman G. J., Young N. S. 1987b; Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro . Blood 70:384–391
     [Google Scholar]
  27. Pattison J. R., Jones S. E., Hodgeson J., Davis L. R., White J. M., Stroud C. E., Murtaza L. 1981; Parvovirus infection and hypoplastic crisis in sickle cell disease. Lancet i:664–665
     [Google Scholar]
  28. Ponnazhagan S., Nallari M. L., Srivastava A. 1994; Suppression of human α-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectors. Journal of Experimental Medicine 179:733–738
     [Google Scholar]
  29. Ponnazhagan S., Woody M. J., Wang X.-S., Zhou S. Z., Srivastava A. 1995; Transcriptional transactivation of parvovirus B19 promoters in non-permissive human cells by adenovirus type 2. Journal of Virology 69:8096–8101
     [Google Scholar]
  30. Saarinen U. M., Chorba T. L., Tattersall P., Young N. S., Anderson L. J., Palmer E., Coccia P. F. 1986; Human parvovirus B19 induced epidemic red cell aplasia in patients with hereditary hemolytic anemia. Blood 67:1411–1417
     [Google Scholar]
  31. Samulski R. J., Chang L.-S., Shenk T. 1987; A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. Journal of Virology 61:3096–3101
     [Google Scholar]
  32. Samulski R. J., Chang L.-S., Shenk T. 1989; Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. Journal of Virology 63:3822–3828
     [Google Scholar]
  33. Schwarz T. F., Serke S., Hottentrager B., von Brunn A., Baurmann H., Kirsch A., Stolz W., Hunn D., Deinhardt F., Roggendrof M. 1992; Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood. Journal of Virology 67:562–566
     [Google Scholar]
  34. Serjeant G. R., Mason K., Topley J. M., Serjeant B. M., Pattison J. R., Jones S. E., Mohamed R. 1981; Outbreak of aplastic crisis in sickle cell anemia associated with parvovirus-like agent. Lancet ii:595–597
     [Google Scholar]
  35. Shade R. O., Blundell M. C., Cotmore S. F., Tattersall P., Astell C. R. 1986; Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. Journal of Virology 58:921–936
     [Google Scholar]
  36. Shimomura S., Komatsu N., Frickhofen N., Anderson S., Kajigaya S., Young N. S. 1992; First continuous propagation of B19 parvovirus in a cell line. Blood 79:18–24
     [Google Scholar]
  37. Spalholz B. A., Tattersall P. 1983; Interaction of minute virus of mice with differentiated cells: strain dependent target-cell specificity is mediated by the intracellular factors. Journal of Virology 46:937–943
     [Google Scholar]
  38. Srivastava A. 1987; Replication of the adeno-associated virus DNA termini in vitro. Intervirology 27:138–147
     [Google Scholar]
  39. Srivastava A., Lu L. 1988; Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow. Journal of Virology 62:3059–3063
     [Google Scholar]
  40. Srivastava C. H., Samulski R. J., Lu L., Larsen S. H., Srivastava A. 1989; Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus. Proceedings of the National Academy of Sciences, USA 86:8078–8082
     [Google Scholar]
  41. Srivastava A., Bruno E., Briddell R., Cooper R., Srivastava C. H., van Besien K., Hoffman R. 1990; Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood 76:1997–2004
     [Google Scholar]
  42. Srivastava C. H., Zhou S. Z., Munshi N. C., Srivastava A. 1992; Parvovirus B19 replication in human umbilical cord blood cells. Virology 189:456–461
     [Google Scholar]
  43. Tuan D. Y. H., Solomon W. B., London I. M., Lee D. P. 1989; An erythroid specific, development stage-independent enhancer far upstream of the human ‘β;-like globin’ genes. Proceedings of the National Academy of Sciences USA 86:2554–2559
     [Google Scholar]
  44. Walsh C. E., Liu J. M., Xiao X., Young N. S., Nienhuis A. W., Samulski R. J. 1992; Regulated high level expression of a human y-globin introduced into erythroid cells by an adeno-associated virus vector. Proceedings of the National Academy of Sciences, USA 89:7257–7261
     [Google Scholar]
  45. Wang X.-S., Yoder M. C., Zhou S. Z., Srivastava A. 1995; Parvovirus B19 promoter at map unit 6 confers autonomous replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic progenitor cells. Proceedings of the National Academy of Sciences, USA 92:12416–12420
     [Google Scholar]
  46. Yaegashi N., Shiraishi H., Takeshita T., Nakamura M., Yajima A., Sugamura K. 1989; Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. Journal of Virology 63:2422–2426
     [Google Scholar]
  47. Zhou S. Z., Broxmeyer H. E., Cooper S., Harrington M. A., Srivastava A. 1993; Adeno-associated virus 2-mediated gene transfer in murine hematopoietic progenitor cells. Experimental Hematology 21:928–933
     [Google Scholar]
  48. Zhou S. Z., Cooper S., Kang L. Y., Ruggieri L., Heimfeld S., Srivastava A., Broxmeyer H. E. 1994; Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. Journal of Experimental Medicine 179:1867–1875
     [Google Scholar]
  49. Zhou S. Z., Li Q., Stomatoyannopoulos G., Srivastava A. 1996; Adeno-associated virus 2-mediated transduction and erythroid cell-specific expression of a normal human /Lglobin gene. Gene Therapy (in press)
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-77-6-1111
Loading
Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection
J. Gen. Virol. 77, 1111 (1996); https://doi.org/10.1099/0022-1317-77-6-1111
/content/journal/jgv/10.1099/0022-1317-77-6-1111
/content/journal/jgv/10.1099/0022-1317-77-6-1111
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error